Keep this in mind when they try to sell you a pandemic

No More Fake News
by Jon Rappoport

Researchers are making noises about a possible new pandemic. One or more variations of bird flu. And of course, in all these ramp-ups, the bottom line is: get vaccinated.

The so-called pandemics train you to obey, so you’ll take all the shots they recommend for every disease, like a good little muffin.

“Seasonal flu? Pandemic flu? Meningitis? Hepatitis? Whooping cough? Measles? Polio? Martian Traveler’s Disease? Venusian Restless Leg? Gimme everything you’ve got. Inject me! Protect me!”

Here are few items to consider when the pandemic professionals start grinding out media warnings.

How many confirmed cases of the disease in question are there, at that moment? Ten? Fifty? A thousand? Out of a population of eight billion?

For example, as Peter Doshi pointed out in BMJ online, when the big push on Swine Flu started, in the spring of 2009, there were only 20 purported cases of Swine Flu. Twenty. (BMJ Online, v.339, b3471)

This is a pandemic?

The mere claim that “a novel virus,” never before seen, has emerged in humans is NOT a slam-dunk for a pandemic. Not by a long shot.

Swine Flu was supposed to be one of those, and it was a dud. The number of deaths reported was far lower than the numbers traditionally reported for seasonal flus.

Number 2, how are doctors or researchers testing patients to confirm they have “pandemic flu?” This is a big issue. If, for example it’s antibody testing, they’re conning you straight out. Why? Because the presence of antibodies (a scouting component of the immune system) is not a sure sign that the person has been ill, is ill now, or will become ill.

Antibodies only indicate a person has contacted the virus in question. That’s it. And until the mid-1980s, when the science was turned upside down for no good reason, a positive antibody test was normally taken to mean the person’s immune system was healthy and had kicked out the virus.

If doctors and researchers are testing people for some purported pandemic virus using the PCR method, there are other problems. The PCR is a procedure that takes tiny, tiny fragments of organic matter from a patient and amplifies them, blows them up, so they can be recognized and read.

However, there is no sure-fire guarantee these fragments are really pieces of viruses. And if the original extraction of such organic material yielded so little from the patient, how on earth would one assume it was causing illness?

Which brings us to the next point. In determining whether a patient has some pandemic illness, and especially early in the game when researchers are still trying to figure out what’s going on, they need to actually isolate that virus from the patient and show it is present in huge numbers in his body. Otherwise, there is no reason to infer the virus is causing disease.

The purported cases of flu in patients could be coming from a number of different factors. A person might be ill as a result of: toxic chemicals, environmental or pharmaceutical; nutritional deficits; stress; parasites, etc.

The biggest issue is: the strength or weakness of that person’s immune system.

In devastated areas, where poverty, contaminated water supplies, starvation, lack of basic sanitation, and overcrowding are chronic, many germs can sweep through the population and cause death, because these people’s immune systems are shot, compromised, on the way out, and can’t defend against the germs.

The same germs, in an affluent area, would cause little harm.

The bottom-line is, to know what is making a person ill, you have to examine that person for many different factors. You can’t just say, “Well, we found a virus in him and therefore that’s why he is sick.”

That’s not science, that’s hype. That’s not research, that’s PR.

As the hype expands and health agencies like the CDC and WHO announce there are thousands of cases of pandemic flu and deaths, they don’t tell you how they’re counting.

That’s a gross omission. For instance, in the summer of 2009, the CDC stopped testing patients who walked into clinics and hospitals with generalized “flu symptoms.” The CDC just assumed they were all suffering from Swine Flu. CBS reporter Sharyl Attkisson reported this fact and it caused a firestorm, until the story was cut off at the knees by the CBS news division.

You want to know what really happens when so-called flu patients are tested?

Here’s a quote from Peter Doshi’s BMJ review, “Influenza: marketing vaccines by marketing disease” (BMJ 2013; 346:f3037):

“…most ‘flu’ appears to have nothing to do with influenza. Every year, hundreds of thousands of respiratory specimens are tested across the US. Of those tested, on average 16% are found to be influenza positive.”


Doshi then states: “…It’s no wonder so many people feel that ‘flu shots’ don’t work: for most flus, they can’t.”

In other words, even if you believe in vaccines, even if you think they’re wonderful and the world would collapse without them, when it comes to the flu, things are not what they seem. 84% of supposed or suspected or diagnosed flu patients are falsely labeled. Even by loose conventional standards, they don’t have the flu. It’s a mirage.

CDC False Statements On Swine H3N2v Matches Raise Concerns


“Human infections with an influenza A (H3N2) variant (H3N2v) virus that contains the M gene from the influenza A(H1N1)pdm09 virus (2009 H1N1 pandemic virus) were first detected in 2011. Notably, a large increase in cases of H3N2v virus infection has been identified since July 2012. (This virus has been circulating among pigs in the U.S. since 2011, has been detected in pigs in many states, and appears to be circulating widely in swine in the U.S.)”

The above comments from the CDC H3N2v August 10, 2012 update for physicians are false. The H3N2v that has increased in humans since July 2012 has not been circulating in many states and data supporting wide circulation is clearly lacking. The July 2012 H3N2v sequences from cases matches the earlier sequences from Utah in March, as well as the West Virginia cases in November and December, 2011. The H3N2v detected in many states has not been reported in a human since November, 2011.

The CDC claims represent pseudoscience and raise serious concerns about the CDC’s abiity to analyze its own data. Moreover, false statements, such as those in the physician’s update are accepted as evidence that the latest H3N2v cases are due to H3N2 jumping from swine to humans, even though the swine distribution supports the jumping of H3N2v from humans to swine.

The H3N2v detected in the initial human cases has not been identified in any swine isolate collected prior to the first human case in July 2011. A recent Journal of Virology paper, “The evolution of novel reassortant A/H3N2v influenza virus in North American swine and humans, 2009-2011”, described 674 MP sequences from swine collections from 2009-2010, as well as 388 HA and NA sequences from these isolates. The extensive survey of USDA public sequences as well as a large series generated by the authors of the paper, identified one match with the H3N2v identified in the first 10 human cases in 2011. This isolate, A/swine/NY/A01104005/2011, was from a September 17, 2011 and was initially noted in November, 2011.

More recently released sequences identified additional matches. However, the earliest matches, A/swine/Iowa/A01202529/2011 and A/swine/Iowa/A01202530/2011, were collected on August 22, 2011 which followed the first human case, A/Indiana/08/2011, which was from July, 2011.

Thus, the extensive USDA surveillance failed to identify any examples of the matching H3N2v in swine prior to the first human case.

Subsequent sequences identified a total of 24 swine isolates from 6 states (Illinois, Indiana, Iowa, New York, Ohio, and Texas) which matched (based on HA, NA, MP sequences) the H3N2v from the first 10 human cases. However none of the 2012 human H3N2v cases, including the sequences from July collections from four outbreaks in three states (Hawaii, Indiana, Ohio), matched the constellation in the 24 swine isolates above (or the first 10 reported human cases in 2011). The July, 2012 H3N2v sequences matched a novel constellation (with an N2 from H3N2 swine), first identified in a large human cluster in at a West Virginia day care center, where the confirmed cases had no swine contact or exposure.

This novel sub-clade has only been identified in two swine isolates from samples collected prior to the July, 2012 cases. These two isolates, A/swine/North Carolina/A01203272/2012 and A/swine/Indiana/A01203509/2012, were collected in 2012, well after the West Virginia cluster from November and December cases.

The absence of any human 2012 cases which match the swine sequences described by the CDC cast serious doubt on the CDC position of swine H3N2 jumps to humans are a major cause of human cases, and instead supports the jump of human H3N2v into swine, leading to widespread detections in swine that follow novel constellations or sequences in humans.

Thus, the false statements by the CDC to physicians and the media continues to raise pandemic concerns and highlights the need for an independent investigation into the ability of the CDC to analyze its sequence data and convey those results to decision makers and the public.

Related: CDC Cites Recent Human H3N2v Transmission
CDC Cites Recent Human H3N2v Transmission
Sustained Efficient Human Community Spread of H3N2v
DARPA demonstrates quick vaccine development for hypothetical pandemic

DARPA’s Blue Angel – Pentagon prepares millions of vaccines against future global flu


The Pentagon’s DARPA lab has announced a milestone, but it doesn’t involve drones or death missiles. Scientists at the Defense Advanced Research Projects Agency say they’ve produced 10 million doses of an influenza vaccine in only one month’s time.

In a press release out of the agency’s office this week, scientists with DARPA say they’ve reach an important step in being able to combat a flu pandemic that might someday decimate the Earth’s population. By working with the Medicago Inc. vaccine company, the Pentagon’s cutting edge research lab says that they’ve used a massive harvest of tobacco plants to help produce a plethora of flu-fighting vaccines.

“Testing confirmed that a single dose of the H1N1 VLP influenza vaccine candidate induced protective levels of hemagglutinin antibodies in an animal model when combined with a standard aluminum adjuvant,” the agency writes, while still noting, though, that “The equivalent dose required to protect humans from natural disease can only be determined by future, prospective clinical trials.”

Researchers have before relied on using chicken eggs to harvest compounds to use in influenza vaccines. With a future outbreak requiring scientists to step up with a solution as soon as possible, though, they’ve turned to tobacco plants to help produce the vaccines.

“Vaccinating susceptible populations during the initial stage of a pandemic is critical to containment,” Dr. Alan Magill, DARPA program manager, says in an official statement. “We’re looking at plant-based solutions to vaccine production as a more rapid and efficient alternative to the standard egg-based technologies, and the research is very promising.”

The World Health Organization has gone on the record to say that as much as half of the people on the planet could be affected by a pandemic in the near future, and it could take as much as nine months for a vaccine for a pandemic virus strain to become made available. With the lives of billions of people across the world at stake, DARPA has been trying to determine new ways of churning out antidotes in as little time as possible. Now its researchers say, that in only a month, scientists “produced more than 10 million doses (as defined in an animal model) of an H1N1 influenza vaccine candidate based on virus-like particles (VLP).”

Through DARPA’s previously established Blue Angel program, researchers have spent several years searching for new ways to produce mass quantities of vaccine-grade protein that could be used to combat what they say are very real emerging and novel biological threats.

Andy Sheldon, Chief Executive Officer of Medicago , says in the company’s own press release that “The completion of the rapid fire test marks a substantial achievement in demonstrating our technology and the potential for Medicago to be the first responder in the event of a pandemic flu outbreak.”

Medicago’s research was conducted in a 97,000-square-foot vaccine facility in North Carolina that was funded through a $21 million Technology Investment Agreement with DARPA.

Related: 30 Years Of Secret, Official Transcripts Reveal Government Vaccine Lies